STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
MONROVIA, Calif., Jan. 8 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will present at the Needham & Company 10th Annual Growth Stock Conference on January 10, 2008 at the New York Palace Hotel. Barry G. Caldwell, STAAR Surgical's Chief Executive Officer, will discuss the Company's business strategy and historical financial performance at 7:30 a.m. Eastern Time.
Attendance at the conference is by invitation only. A live audio webcast of STAAR's presentation may be accessed through the Company's website at http://www.staar.com. An archived replay of the presentation will be available after the live presentation and can also be accessed at http://www.staar.com.
About STAAR Surgical
STAAR is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. More information is available at http://www.staar.com.
CONTACT: Investors Media
EVC Group EVC Group
Douglas Sherk/Donald Takaya, Steve DiMattia,
415-896-6820 646-201-5445
SOURCE STAAR Surgical Company
-0- 01/08/2008
/CONTACT: investors, Douglas Sherk or Donald Takaya, +1-415-896-6820; or
media, Steve DiMattia, +1-646-201-5445, all of EVC Group for STAAR Surgical
Company /
/Web site: http://www.staar.com /
(STAA)
CO: STAAR Surgical Company; Tenth Annual Needham Growth Conference
ST: California, New York
IN: HEA MTC
SU: TDS CCA
WB-DW
-- AQTU132 --
3481 01/08/2008 12:18 EST http://www.prnewswire.com